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Downstream Coronary Stenoses: Validation in Humans
Andy S. Yong1, Gabor Toth2, Guy Lenders3, Bernard De Bruyne2, Catherine Dao1,
David V. Daniels1, Nico Pijls3, William F. Fearon1
1Stanford University Medical Center, Stanford, CA, 2Cardiovascular Center Aalst,
Aalst, Belgium, 3Catharina Hospital, Eindhoven, The Netherlands
Background: Fractional ﬂow reserve (FFR) measurement can aid in the assessment of
left main coronary stenosis. We have previously shown in an animal model that the
presence of downstream epicardial stenosis can affect left main FFR measurement.
The aim of this study is to explore the effect of stenosis in a downstream epicardial
artery on left main FFR assessment in humans.
Methods: After elective coronary intervention of either the left anterior descending
(LAD) or left circumﬂex (LCX) artery, an intermediate left main stenosis was created
using an uninﬂated “winged” balloon. Variable stenoses were then created in the
downstream vessel using a balloon inﬂated within the newly placed stent. A total of 67
pairs of left main FFR assessments in 16 patients were obtained, before and after
creation of a stenosis in the downstream vessel, with a pressure wire in the non-
stenosed downstream vessel.
Results: The apparent left main FFR in the presence of downstream stenosis
(FFRapp) was modestly higher than the true FFR in the absence of downstream
stenosis (FFRtrue) (0.820.07vs.0.800.07, p<0.001). The difference between
FFRtrue and FFRapp correlated with composite FFR of the left main plus stenosed
artery (FFRepicardial) (r¼-0.36, p<0.001), and this difference was only signiﬁcant
when FFRepicardial was severe (ﬁgure below). Among the 67 measurements, only 2
(3%) had a difference between FFRtrue and FFRapp of >0.5, and the FFRepicardial
was <0.2 in both cases.Conclusions: A clinically signiﬁcant effect on the FFR assessment of left main
disease with occurs only when the stenosis in the other vessel is severe.
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Background: Regadenoson is an A2A-receptor selective hyperemic stimulus known
by its rapid onset and simple method of administration. We compared the hyperemic
effect of single bolus regadenoson injection to central venous adenosine infusion for
measuring Fractional Flow Reserve (FFR). Moreover, time intervals to onset and
duration of steady state maximum hyperemia were studied, central venous versus
peripheral injections of regadenoson were compared, and safety of repeated injections
of regadenoson was investigated.
Methods: Fifty patients with angiographic intermediate CAD scheduled for
measurement of FFR were enrolled. FFR was measured twice by central venous
adenosine (140 mg/kg/min) and twice by central or peripheral venous regadenoson
bolus injection (400 mg) in a randomized sequence.
Results: Patients had a mean age of 658 years and 80% was male. The stenosis under
investigation was located in the LAD, CX, and RCA in 60%, 28% and 11% respec-
tively. There was no difference in FFR measured by adenosine or by regadenoson (R2
¼ 0.981, DFFR ¼ 0.000.02, p<0.001), neither between repeated bolus injections of
regadenoson (R2¼ 0.971, DFFR¼ 0.000.02, p<0.001). The onset of hyperemia was
achieved within 2912s, maximum hyperemia lasted 151s with a wide variation
between 15 and >600s. No noticeable side-effects of the drugs were observed.B188 JACC Vol 62/18/Suppl B j October 27–NovemConclusions: Regadenoson is an excellent alternative for adenosine to induce
maximum hyperemia. Its ease in administration, rapid onset and duration of maximum
hyperemia make it an excellent hyperemic stimulus. Repeated injection of regade-
noson is safe.
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Background: A central tenant of fractional ﬂow reserve (FFR) is that ﬂow increases
following administration of vasodilators. However, animal studies show the increases
in ﬂow are limited to mild stenoses and unobstructed vessels, whilst the incremental
beneﬁt of vasodilator administration to more signiﬁcant stenoses may be negligible. In
this study, we assess this in humans, using FFR as a physiological measure of stenosis
severity over various phases of the cardiac cycle.
Methods: Pressure and ﬂow velocity were simultaneously measured at rest and during
adenosine-mediated hyperemia using intra-coronary wires in 146 stenosis in patients
undergoing stenosis assessment. Resting and hyperemic whole-cycle ﬂow (FlowRwc
and FlowHwc), resting wave-free ﬂow (Flowwfp), and fractional ﬂow reserve were
calculated.
Results: In non-signiﬁcant coronary lesions by FFR, hyperemic whole cycle ﬂow
was consistently higher than resting wave-free ﬂow: D0.140.02m/s in lesions with
FFR 0.81-0.90, and D0.220.04m/s in lesions with FFR 0.91-1.0 (p<0.001 for
both). In contrast, in signiﬁcant lesions by FFR the mean difference in Flowwfp and
FlowHwc was 0.030.01m/s when FFR0.80 and 0.020.01m/s when FFR0.75,
both signiﬁcantly less than when FFR>0.80 or >0.75 (p<0.001). Overall in phys-
iologically signiﬁcant stenoses deﬁned by FFR 0.75 or FFR0.80, resting Flowwfp
represented 100%, and 97% of hyperemic FlowHwc respectively. In contrast, resting
whole cycle ﬂow represented a signiﬁcantly smaller fraction of FlowHwc in signiﬁ-
cant stenoses (76% and 74% respectively, p<0.001 for both) and was signiﬁcantly
lower than Flowwfp for both signiﬁcant and non-signiﬁcant stenoses (p<0.001
for all).
Conclusions: Adenosine does not signiﬁcantly increase ﬂow compared to the wave-
free period in stenoses deﬁned as signiﬁcant by FFR. Adenosine only increases ﬂow
compared to resting whole cycle and wave-free period when stenoses are physio-
logically non-signiﬁcant. This may have important implications for physiological
stenosis assessment.
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Background: There is still much room for improvement in developing a robust
noninvasive model for predicting fractional ﬂow reserve (FFR). We aimed to deter-
mine the application of advanced coronary computed tomography angiography (A-
CCTA) for predicting invasive FFR in intermediate coronary lesions.
Methods: Sixty-one patients with 71 single intermediate coronary lesions (50-80%
stenosis) on CCTA prospectively underwent coronary angiography and FFR.
Advanced anatomical and morphometric plaque analysis was performed based on
CCTA data set to determine optimal criteria for signiﬁcant ﬂow impairment. A
signiﬁcant stenosis was deﬁned as FFR 0.80.
Results: FFR averaged 0.85  0.09, and 19 lesions (27%) were functionally
signiﬁcant. FFR correlated with minimum lumen area (MLA) (r ¼ 0.456,
p <0.001), minimum lumen diameter (MLD) (r ¼ 0.326, p ¼ 0.006), reference LD
(r ¼ 0.245, p¼0.039), plaque burden (r ¼ -0.313, p ¼ 0.008), lumen area stenosis
(r ¼ -0.305, p ¼ 0.01), lesion length (r ¼ -0.692, p <0.001), and plaque volume
(r ¼ -0.668, p <0.001). There was no relationship between FFR and CCTA
morphometric plaque parameters. By multivariate analysis the independent predic-
tors of FFR were lesion length (beta ¼ -0.581, p <0.001), MLA (beta ¼ 0.360, p ¼
0.041), and reference LD (beta ¼ -0.255, p ¼ 0.036). The optimal cutoffs for lesion
length, MLA, MLD, reference LD, and lumen area stenosis were >18.5mm,ber 1, 2013 j TCT Abstracts/POSTER/Physiologic Lesion Assessment
